特拉斯图祖马布德鲁克斯提可有效控制复发性卵巢大细胞神经内分泌癌与低水平的HER-2表达:一个病例报告

Yurou Xing1, Yidan Cao2, Xin Wu3

  • 1Thoracic Oncology Ward, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Frontiers in oncology
|February 12, 2024
PubMed
概括

卵巢的大细胞神经内分泌癌 (LCNEC) 是一种罕见且具有攻击性的癌症. 特拉斯图祖马布德鲁克斯泰坎对复发性卵巢LCNEC与低HER2表达有前途,提供了一个新的治疗途径.

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K